Zearalenone is a mycotoxin produced by Fusarium spp. 11 β -Hydroxysteroid dehydrogenases, isoforms 1 (HSD11B1) and 2 (HSD11B2), have been demonstrated to be the regulators of the local level of active glucocorticoid, which has a broad range of physiological actions. In the present study, the potency of zearalenone was tested for the inhibition of HSD11B1 and HSD11B2 in rat and human tissues. Zearalenone showed potent inhibition of HSD11B2 with the half-maximal inhibitory concentration (IC 50 ) calculated at 49.63 and 32.22 μ M for the rat and human, respectively. Results showed that zearalenone competitively inhibited HSD11B2 when a steroid substrate was used. However, it served as an uncompetitive inhibitory factor when the cofactor NAD + was used. In contrast, the potency of zearalenone to inhibit both rat and human HSD11B1 was diminished, with the concentration of 100 μ M causing almost no inhibitory effect on the isoform. In conclusion, we observed that zearalenone is a selective inhibitor of HSD11B2, implying that this agent may cause excessive glucocorticoid action in local tissues such as kidney and placentas.
Li, L., Wu, X., Guan, H., Mao, B., Wang, H., Yuan, X., … Ge, R. S. (2015). Zearalenone Inhibits Rat and Human 11 β -Hydroxysteroid Dehydrogenase Type 2. BioMed Research International, 2015. https://doi.org/10.1155/2015/283530